GAIN: Biomarkers to Predict Gain From Therapy in Motor Stroke

Sponsor
Institut National de la Santé Et de la Recherche Médicale, France (Other)
Overall Status
Unknown status
CT.gov ID
NCT03739892
Collaborator
(none)
20
1
1
23
0.9

Study Details

Study Description

Brief Summary

The aim is to determine predictors of treatment response, i.e gain from rehabilitation training, in post stroke upper limb deficits. The investigators will like to answer the following question: "What is this patient's potential for recovery, given his profile?" The investigators propose to conduct a longitudinal physiopathological study on the stroke patients with motor deficits who entered the rehab center of Pitié Salpêtrière hospital. The investigators will benefit from the organization, which is already in place (clinical asssessments and training) to add MRI, TMS and EEG recordings, as well as genotype analysis before the training offered in the rehabilitation unit. The investigators will repeat these assessments after the training (immeadiately and 6 weeks after).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: standard stroke rehabilitation
N/A

Detailed Description

The protocol is based on 10 visits. The three main one are V1, V9 and V10. V1, V9 and V10 are the assessments visits with clinical scores, MRI TMS and EEG recordings. These are made before the training (V1), immediately after the 6 weeks of training (V9) and 6 weeks after (V10) V5 is a visit where the investigators will clinically assess the patients at three weeks of the training.

The other visits (V2, V3, V4, V6, V7, V8) consist in recording an EEG while patients are under training each week during six weeks.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
physiopathological studyphysiopathological study
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Biomarkers to Predict Gain From Therapy in Motor Stroke
Anticipated Study Start Date :
Nov 1, 2018
Anticipated Primary Completion Date :
Aug 1, 2020
Anticipated Study Completion Date :
Oct 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: stroke patients

stroke patients with upper limb motor deficit receiving standard care of rehab

Behavioral: standard stroke rehabilitation
standard rehabilitation according to the french standard care and to the severity of the patient

Outcome Measures

Primary Outcome Measures

  1. Changes in a composite motor score post-pre training is the gain from therapy Candidates biomarkers: MRI, EEG, TMS, genotype [6 weeks between pre and post assessment]

    Changes in motor score Candidates biomarkers: MRI, EEG, TMS, genotypes post-pre training is the gain from therapy

Secondary Outcome Measures

  1. Changes in a composite motor score post-pre training is the gain from therapy [12 weeks between pre and post assessment]

    Changes in motor score Candidates biomarkers: MRI, EEG, TMS, genotypes post-pre training is the gain from therapy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

(i) First-ever stroke patients (ii) Upper limb motor impairment (Fugl Meyer scale) (iii) post stroke delay between 7 and 42 days (iv) affiliated to french health care (v) Suitable for task based oriented training in the rehab center

Exclusion Criteria:

(i) age < 18 or > 85 years (ii) Hemianopia (iii) contra-indications to MRI or TMS assessments (iv) life threatening conditions (v) patients under legal protection (vi) pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 ICM Paris France 75013

Sponsors and Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Institut National de la Santé Et de la Recherche Médicale, France
ClinicalTrials.gov Identifier:
NCT03739892
Other Study ID Numbers:
  • C17-54
First Posted:
Nov 14, 2018
Last Update Posted:
Nov 14, 2018
Last Verified:
Nov 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 14, 2018